Role of the antioxidant transcription factor Nrf2 in determining susceptibility to non-alcoholic steatohepatitis in a human liver cell model
PhD
In Dundee
Description
-
Type
PhD
-
Location
Dundee (Scotland)
-
Duration
Flexible
-
Start date
Different dates available
Non-alcoholic fatty liver disease (NAFLD) is a major public health concern in the UK as it is associated with obesity, and has huge economic significance. It ranges from simple steatosis through to non-alcoholic steatohepatitis (NASH), to cirrhosis and hepatocellular carcinoma [1]. The molecular events driving NASH are unclear, but it most likely entails interplay between oxidative stress, insulin resistance and inflammation, in response to a high-energy diet.
Facilities
Location
Start date
Start date
Reviews
This centre's achievements
All courses are up to date
The average rating is higher than 3.7
More than 50 reviews in the last 12 months
This centre has featured on Emagister for 13 years
Subjects
- Antioxidant
- Animals
- Exhibited
- Surprisingly
- Decreased
- Hepatic
- Antagonizes
- Oxidation
- Energy
- Enzymes
Course programme
The project will test the hypotheses that Nrf2 controls redox signaling and energy sensing in cells provided with excess nutrients. Moreover, it will explore Nrf2 regulation in human cell models of NAFLD (hepatoblastoma C3A cells treated with LPON, and an induced pluripotent stem cell (iPSC) model) [3]. Human liver tissue will also be used to validate our findings. Models will assess the impact of variable dietary lipids and sugars (reflecting human diet) on cellular redox signaling, AMPK signaling and energy sensing, and the role played by Nrf2 in attenuating these processes. The effects of Nrf2 will be explored by employing genetic and pharmacological up-regulation of the transcription factor, and also siRNA knockdown of Nrf2. Key measures in the models will be oxidative balance of the cell in response to the flux of sugars and free fatty acids either to oxidation via the TCA cycle or to lipogensis, lipid elongation and esterification to triglyceride.
In addition, to the examination of regulation of sugar and lipid metabolism by genetic and pharmacological manipulation of Nrf2, we will explore cross talk between Nrf2 and the NFkappaB/TNFalpha axis, as a mechanism responsible for the switch from steatosis (viewed as successful adaptation) to steato-hepatitis (i.e. a pro-inflammatory state) allowing exploration of the role of candidate therapeutic agents. In particular, the relative importance of redox signaling, ER stress and the inflammasome in triggering an inflammatory response will be examined.
Role of the antioxidant transcription factor Nrf2 in determining susceptibility to non-alcoholic steatohepatitis in a human liver cell model